An African Patient With Ziprasidone Intolerance
J Clin Psychiatry 2005;66(6):800[letter]
© Copyright 2017 Physicians Postgraduate Press, Inc.
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
The issue of ethnopsychopharmacology has been receiving
increased attention lately. One study showed significant differences
in treatment response in schizophrenia between various
but data on the subject are sparse, particularly for
newer antipsychotic drugs. We report on a patient of African descent
who developed intolerable side effects in response to ziprasidone,
a recently approved atypical antipsychotic medication.